EP0973582A1 - Electrotherapy current waveform - Google Patents

Electrotherapy current waveform

Info

Publication number
EP0973582A1
EP0973582A1 EP97954585A EP97954585A EP0973582A1 EP 0973582 A1 EP0973582 A1 EP 0973582A1 EP 97954585 A EP97954585 A EP 97954585A EP 97954585 A EP97954585 A EP 97954585A EP 0973582 A1 EP0973582 A1 EP 0973582A1
Authority
EP
European Patent Office
Prior art keywords
storage device
charge storage
discharge
phase
current
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP97954585A
Other languages
German (de)
French (fr)
Other versions
EP0973582A4 (en
EP0973582B1 (en
Inventor
Shervin Ayati
Michael L. Lopin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZMD Corp
Original Assignee
ZMD Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/769,778 external-priority patent/US5769872A/en
Priority claimed from US08/769,776 external-priority patent/US5733310A/en
Priority claimed from US08/769,777 external-priority patent/US5800463A/en
Priority claimed from US08/769,045 external-priority patent/US5800462A/en
Priority claimed from US08/769,773 external-priority patent/US6096063A/en
Priority claimed from US08/769,046 external-priority patent/US5797968A/en
Priority claimed from US08/910,757 external-priority patent/US5904706A/en
Application filed by ZMD Corp filed Critical ZMD Corp
Priority to EP05075510A priority Critical patent/EP1535645A1/en
Publication of EP0973582A1 publication Critical patent/EP0973582A1/en
Publication of EP0973582A4 publication Critical patent/EP0973582A4/en
Application granted granted Critical
Publication of EP0973582B1 publication Critical patent/EP0973582B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3904External heart defibrillators [EHD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • A61N1/3937Monitoring output parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • A61N1/3937Monitoring output parameters
    • A61N1/3943Monitoring output parameters for threshold determination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3956Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave
    • A61N1/3912Output circuitry therefor, e.g. switches

Definitions

  • This invention relates to electrotherapy circuits and more particularly relates to external defibrillators that apply defibrillation shocks to a patient's heart through electrodes placed externally on the patient's body or externally on the patient's heart during surgery.
  • electro-chemical activity within a human heart causes the organ's muscle fibers to contract and relax in a synchronized manner.
  • This synchronized action of the heart's musculature results in the effective pumping of blood from the ventricles to the body' s vital organs.
  • VF ventricular fibrillation
  • abnormal electrical activity within the heart causes the individual muscle fibers to contract in an unsynchronized and chaotic way. As a result of this loss of synchronization, the heart loses its ability to effectively pump blood.
  • the current required for effective defibrillation is dependent upon the particular shape of the current waveform, including its amplitude, duration, shape (i.e., sine, damped sine, square, exponential decay) , and whether the current waveform has a single polarity (monophasic) or has both positive and negative polarity (biphasic) . It has been suggested that large defibrillation currents may cause damage to cardiac tissue, however.
  • the invention provides a method and circuit for forming an electrotherapy current waveform.
  • a charge storage device located externally of a patient's body is charged, and is discharged through the patient's body through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device.
  • a continuous discharge of the charge storage device through the electrodes is controlled so as to produce at least one phase of a current waveform that includes a ripple.
  • the phase of the waveform having the ripple is a substantially rectilinear positive phase of a biphasic waveform.
  • any sawtooth ripple in either phase of the waveform should preferably have a height less than about one-quarter of the average height of the phase, and more preferably less than about one- sixth of the average height of the phase, in order to further minimize the threshold of average current required for effective defibrillation and the possibility of damaging the patient's tissue.
  • the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, and more preferably less than one-fourth or one-fifth of the peak current of the phase.
  • the electrotherapy circuit includes a resistive circuit connected between the charge storage device and one of the electrodes, and a control circuit. The control circuit is connected to the resistive circuit and controls the resistance of the resistive circuit during discharge of the charge storage device so as to shape a current waveform produced between the discharge electrodes .
  • the resistors that are present in the defibrillation path are successively shorted out, thereby creating a sawtooth approximation to a rectilinear shape in the output current (output decays and then jumps up every time a resistor is shorted out) .
  • the invention provides an improved, low-cost way of creating a biphasic waveform having a rectilinear first phase.
  • Resistors are relatively inexpensive as compared with capacitors, and a total of N steps in resistance values can be obtained with log 2 N resistors, as opposed to N capacitors, simply by connecting the resistors in series in a binary sequence (1-2-4-etc.) . Because resistors are used instead of capacitors, no circuitry is required to equalize voltages on capacitors upon recharge or to prevent reversal of voltages on capacitors .
  • variable resistor stage that tends to smooth out the ripple pattern.
  • the variable resistor stage is a circuit that is reset to its maximum resistance value every time one of the fixed- value resistors is shorted out and then decreases to zero over the time interval before the next resistance step reduction.
  • Another advantage of the invention is that the resistors in the defibrillation path inherently protect against possible short circuits.
  • the electrotherapy circuit includes a variable impedance connected between the charge storage device and one of the electrodes, a sensor that senses a patient-dependent electrical parameter (such as a patient impedance sensor), and a control circuit.
  • the control circuit is connected to the sensor and the variable impedance and controls the variable impedance during discharge of the charge storage device based on a patient-dependent electrical parameter (such as the patient impedance) sensed by the sensor.
  • the discharge is controlled in a manner so as to reduce the dependence of peak discharge current on the electrical parameter for a given amount of charge stored by the charge storage device.
  • the electrotherapy circuit By controlling the discharge of the charge storage device based on the sensed patient impedance, it is possible to limit the difference in the peak current that passes through a low-impedance patient as compared with a high- impedance patient. Thus, the current is made more constant over a range of patient impedances, and the electrotherapy circuit provides effective defibrillation while maintaining controlled current levels to reduce any possibility of damage to heart, skin, and muscle tissue.
  • the impedance of a patient when a large direct current is passing through the patient is different from the impedance of the patient when a small current is passing through the patient or when an alternating current is passing through the patient.
  • the current level of the sensing portion should always be at least one-third, and more preferably one-half, of the current level at the beginning of the therapeutic discharge portion in order to ensure detection of a patient impedance that is similar to the impedance of the patient during the therapeutic discharge portion.
  • Fig. 1 is a diagram of a current waveform produced by a electrotherapy circuit according to the invention.
  • Fig. 2 is a diagram of the key elements of electrotherapy circuit according to the invention.
  • Figs. 10A and 10B is a set of schedules of the resistance values used for generating the waveforms shown in Figs. 6-10B.
  • Fig. 11 is a table of waveform parameters for various patient impedances in a "normal" mode of operation and a "high-energy” mode of operation of an electrotherapy circuit according to the invention.
  • the biphasic defibrillation waveform immediately after the sensing pulse, the biphasic defibrillation waveform has an initial discharge current that is controlled by microprocessor 46 based on the patient impedance sensed by current -sensing transformer 64.
  • the current waveform decreases through a series of rapid steps from the end of the positive phase to the beginning of negative phase, one of the steps being at the zero crossing.
  • Microprocessor 46 accomplishes this by 1) successively increasing the resistance of resistive circuit 50 in fixed increments through manipulation of resistor-shorting switches 58, 60, and 62, then 2) opening all of the switches in H-bridge 48 to bring the current waveform down to the zero crossing, then 3) reversing the polarity of the current waveform by closing the H-bridge switches that had previously been open in the positive phase of the current waveform, and then 4) successively decreasing the resistance of resistance circuit 50 in fixed increments through manipulation of resistor-shorting switches 58, 60, and 62 until the resistance of resistance circuit 50 is the same as it was at the end of the positive phase.
  • variable resistor 66 is provided in series with the other resistors 52, 54, and 56 to reduce the sawtooth ripple. Every time one of the fixed-value resistors 52, 54, or 56 is shorted out, the resistance of variable resistor 66 automatically jumps to a high value and then decreases until the next fixed- value resistor is shorted out. This tends, to some extent, to smooth out the height of the sawtooth ripple from about 3 amps to about 0.1 to 0.2 amps, and reduces the need for smaller increments of the fixed-value resistors (i.e., it reduces the need for additional fixed-value resistor stages) .
  • the rectilinear phase may exhibit a degree of tilt, either slightly up, or slightly down. This occurs because of the "graininess" of the steps, because patient impedance may change during the waveform, and because of inherent inaccuracies of circuit elements. For example, with respect to graininess of the steps, calculations might show that, for a 50-ohm patient, the optimal resistance required at the end of the rectilinear phase is 14 ohms, in which case we must choose between 10 or 20 ohms based on the available fixed-value resistors.
  • capacitor 115 ⁇ F and voltage (2200 volts) are based on the desired current requirements and allowable droop during the negative phase.
  • the capacitor stores the minimum energy required to meet the delivered charge requirements (i.e., the charge required to produce the desired current waveform having the desired duration) .
  • the switches in the left-hand side of H-bridge 48 can be tested by closing switches 17 and 19, opening switches 26 and 28, closing switches 30 and 32, then after a short time closing switches 42 and 44, then after a short time opening switches 30 and 32, and then after a short time opening switches 42 and 44. If the switches are working properly, current-sensing transformer 64 will sense the passage of current when all four switches are closed, and will sense no current when switches 30 and 32 or switches 42 and 44 are open. Otherwise, current- sensing transformer 64 will detect the possible presence of a short circuit or an open circuit .
  • the switches in the right-hand side of H-bridge 48 can be tested by closing switches 38 and 40, then after a short time closing switches 34 and 36, then after a short time opening switches 38 and 40, and then after a short time opening switches 34 and 36.
  • This valuable safety test does not require current to pass through the patient, due to the placement of current-sensing transformer 64 outside the legs of H-bridge 48.
  • the resistive circuit 50 of Fig. 2 includes resistors 52 (10 ohms) , 54 (two 10-ohm resistors) , and 56 (four 10-ohm resistors) and IGBT shorting switches 58, 60, and 62.
  • resistors 52 (10 ohms)
  • 54 two 10-ohm resistors
  • 56 four 10-ohm resistors
  • IGBT shorting switches 58, 60, and 62 Alternatively, other semiconductor switching devices may be used.
  • the resistor string is designed to switch in 10-ohm steps. This allows for a maximum resistance of 80-ohms (including the 10-ohm variable resistor) , which makes it possible to limit patient current to 21.5 amps for a 15- ohm patient resistance (the current pulse would be 25.6 amps in the event of a short circuit between the electrodes) .
  • the electrotherapy circuit can be operated in either a "normal” mode of operation or a "high-energy” mode of operation. These two modes of operation are identical when the sensed patient impedance is below 40 ohms. If the sensed patient impedance is above 40 ohms, however, the microprocessor selects an initial resistance value of the series-connected resistors (after the sensing pulse) that depends on the mode of operation. In particular, in the "high-energy” mode of operation the microprocessor selects a lower initial resistance than in the "normal” mode of operation. Thus, more energy will be delivered to the patient in the "high-energy” mode of operation than in the "normal” mode of operation. A practitioner may try to defibrillate in the "normal” mode, then switch to the "high-energy” mode if unsuccessful .

Abstract

The invention provides a method and circuit for forming an electrotherapy current wave form. A charge storage device located externally of a patient's body is charged, and is discharged through the patient's body (24) through at least two discharge electrodes (21, 23) connected by electrical circuitry to opposite poles of the charge storage device. A continuous discharge of the charge storage device through the electrodes is controlled so as to produce at least one phase of a current wave form that includes a ripple (14). The ripple has a height less than one third of the height of the peak current of the phase. The current wave form has a sensing pulse portion (10) that is integral with the therapeutic discharge portion of the current wave form.

Description

ELECTROTHERAPY CURRENT WAVEFORM Background of the Invention This invention relates to electrotherapy circuits and more particularly relates to external defibrillators that apply defibrillation shocks to a patient's heart through electrodes placed externally on the patient's body or externally on the patient's heart during surgery. Normally, electro-chemical activity within a human heart causes the organ's muscle fibers to contract and relax in a synchronized manner. This synchronized action of the heart's musculature results in the effective pumping of blood from the ventricles to the body' s vital organs. In the case of ventricular fibrillation (VF) , however, abnormal electrical activity within the heart causes the individual muscle fibers to contract in an unsynchronized and chaotic way. As a result of this loss of synchronization, the heart loses its ability to effectively pump blood.
Defibrillators produce a large current pulse that disrupts the chaotic electrical activity of the heart associated with ventricular fibrillation and provide the heart's electro-chemical system with the opportunity to re-synchronize itself. Once organized electrical activity is restored, synchronized muscle contractions usually follow, leading to the restoration of effective cardiac pumping.
The current required for effective defibrillation is dependent upon the particular shape of the current waveform, including its amplitude, duration, shape (i.e., sine, damped sine, square, exponential decay) , and whether the current waveform has a single polarity (monophasic) or has both positive and negative polarity (biphasic) . It has been suggested that large defibrillation currents may cause damage to cardiac tissue, however.
It is known to construct an external defibrillator that can sense patient impedance and can set the durations of the first and second phases of a biphasic waveform as a function of the patient impedance. An example of such a defibrillator is described in PCT Patent Publication No. WO 95/05215. Fain et al . , U.S. Pat. No. 5,230,336 discloses a method of setting pulse widths of monophasic and biphasic defibrillation waveforms based on measured patient impedance. Kerber et al . , "Advance Prediction of Transthoracic Impedance in Human Defibrillation and Cardioversion: Importance of Impedance in Determining the Success of Low-Energy Shocks," 1984, discloses a method of selecting the energy of defibrillation shocks based on patient impedance measured using a high-frequency signal.
It is also known to construct a defibrillator with a safety resistor in the defibrillation path (PCT Patent Publication No. WO 95/05215) . Before application of a defibrillation waveform to a patient, a test pulse is passed through the safety resistor while a current sensor monitors the current. If the sensed current is less than a safety threshold representative of a short circuit, the safety resistor is removed and the defibrillation waveform is applied to the patient.
It is known, in an implantable defibrillator, to use a biphasic waveform having a first phase consisting of multiple truncated decaying exponentials that form a sawtooth approximation of a rectilinear shape (Kroll, U.S. Patent No. 5,199,429). This is accomplished by charging a set of energy storage capacitors and then successively allowing individual capacitors to discharge during the first phase, thereby creating the sawtooth pattern in the output current of the circuit. A more recent patent, Kroll, U.S. Patent No. 5,514,160, describes a biphasic waveform, in an implantable defibrillator, having a rectilinear-shaped first phase created by placing a MOSFET current limiter in the defibrillation path. This patent states that the grossly non-linear current limiter looks like a small and declining resistance to the capacitor. Also, Schuder et al . , "Transthoracic Ventricular Defibrillation in the 100 kg Calf with Symmetrical One-Cycle Bidirectional Rectangular Wave Stimuli" describes the use of biphasic waveforms having rectilinear first and second phases to reverse ventricular fibrillation in calves. Stroetmann et al . , U.S. Patent No. 5,350,403, discloses a waveform having a sawtooth ripple that is formed by periodically interrupting a non-continuous discharge of a charging circuit .
Summary of the Invention The invention provides a method and circuit for forming an electrotherapy current waveform. According to one aspect of the invention, a charge storage device located externally of a patient's body is charged, and is discharged through the patient's body through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device. A continuous discharge of the charge storage device through the electrodes is controlled so as to produce at least one phase of a current waveform that includes a ripple.
In preferred embodiments the phase of the waveform having the ripple is a substantially rectilinear positive phase of a biphasic waveform. We believe that the use of a waveform having a substantially rectilinear positive phase tends to minimize the threshold of average current required for effective defibrillation, and tends to avoid damaging the patient's tissue even if the total energy applied to the patient is relatively high.
According to another aspect of the invention, the ripple has a height (upward jump) less than one-third of the height of the peak current of the phase, and more preferably less than one- fourth or one- fifth of the height of the peak current of the phase, in order to provide a lower threshold of average current required for effective defibrillation and minimize the possibility of damaging the patient's tissue. In certain embodiments this phase is followed by another phase of the current waveform having an opposite polarity and a shorter duration. We believe the duration of the phase that includes the ripple should be between 50 and 70 percent (e.g., three-fifths or five-eighths) of the combined duration of the phase that includes the ripple and the other phase. We also believe that any sawtooth ripple in either phase of the waveform should preferably have a height less than about one-quarter of the average height of the phase, and more preferably less than about one- sixth of the average height of the phase, in order to further minimize the threshold of average current required for effective defibrillation and the possibility of damaging the patient's tissue. According to other aspects of the invention, the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, and more preferably less than one-fourth or one-fifth of the peak current of the phase. According to another aspect of the invention, the electrotherapy circuit includes a resistive circuit connected between the charge storage device and one of the electrodes, and a control circuit. The control circuit is connected to the resistive circuit and controls the resistance of the resistive circuit during discharge of the charge storage device so as to shape a current waveform produced between the discharge electrodes .
In preferred embodiments the resistive circuit includes a set of resistors connected together in series. In preferred embodiments the control circuit decides, based on the patient impedance sensed during an initial sensing pulse portion of the discharge of the charge storage device, how many (if any) resistors to include in the defibrillation path at the beginning of a therapeutic discharge portion of the discharge of the charge storage device (e.g., at the beginning of a biphasic defibrillation waveform) . This may mean, depending on the sensed patient impedance, that the current level steps up from the sensing pulse to the beginning of the biphasic defibrillation waveform. Once the biphasic defibrillation waveform begins, the resistors that are present in the defibrillation path are successively shorted out, thereby creating a sawtooth approximation to a rectilinear shape in the output current (output decays and then jumps up every time a resistor is shorted out) .
The invention provides an improved, low-cost way of creating a biphasic waveform having a rectilinear first phase. Resistors are relatively inexpensive as compared with capacitors, and a total of N steps in resistance values can be obtained with log2N resistors, as opposed to N capacitors, simply by connecting the resistors in series in a binary sequence (1-2-4-etc.) . Because resistors are used instead of capacitors, no circuitry is required to equalize voltages on capacitors upon recharge or to prevent reversal of voltages on capacitors .
Certain embodiments include a variable resistor stage that tends to smooth out the ripple pattern. The variable resistor stage is a circuit that is reset to its maximum resistance value every time one of the fixed- value resistors is shorted out and then decreases to zero over the time interval before the next resistance step reduction.
Another advantage of the invention is that the resistors in the defibrillation path inherently protect against possible short circuits.
According to another aspect of the invention, the electrotherapy circuit includes a variable impedance connected between the charge storage device and one of the electrodes, a sensor that senses a patient-dependent electrical parameter (such as a patient impedance sensor), and a control circuit. The control circuit is connected to the sensor and the variable impedance and controls the variable impedance during discharge of the charge storage device based on a patient-dependent electrical parameter (such as the patient impedance) sensed by the sensor. According to another aspect of the invention, the discharge is controlled in a manner so as to reduce the dependence of peak discharge current on the electrical parameter for a given amount of charge stored by the charge storage device. By controlling the discharge of the charge storage device based on the sensed patient impedance, it is possible to limit the difference in the peak current that passes through a low-impedance patient as compared with a high- impedance patient. Thus, the current is made more constant over a range of patient impedances, and the electrotherapy circuit provides effective defibrillation while maintaining controlled current levels to reduce any possibility of damage to heart, skin, and muscle tissue. According to another aspect of the invention, the discharge of the charge storage device includes a current waveform having a sensing pulse portion, with insufficient energy for performing therapy, during which the sensor senses the patient-dependent electrical parameter, and a therapeutic discharge portion, with sufficient energy for performing therapy, having an initial discharge current controlled by the control circuit based on the patient -dependent electrical parameter as sensed by the sensor. The sensing pulse portion has a discharge current that is at least about one-third of the initial discharge current of the therapeutic discharge portion.
The impedance of a patient when a large direct current is passing through the patient is different from the impedance of the patient when a small current is passing through the patient or when an alternating current is passing through the patient. We believe that the current level of the sensing portion should always be at least one-third, and more preferably one-half, of the current level at the beginning of the therapeutic discharge portion in order to ensure detection of a patient impedance that is similar to the impedance of the patient during the therapeutic discharge portion.
According to another aspect of the invention, the discharge of the charge storage device occurs without recharging of the charge storage device between the sensing pulse portion and the therapeutic discharge portion of the current waveform.
Thus, it is possible to apply paddles to the chest of the patient (or apply hand-held spoons directly to the patient's heart during open heart surgery) and immediately discharge the sensing pulse and then discharge the biphasic defibrillation waveform immediately after the sensing pulse. This is particularly important because the patient (or the patient's heart) may move and because it is difficult for a practitioner to apply a constant force to the patient's skin (or the patient's heart).
Numerous other features, objects, and advantages of the invention will become apparent from the following detailed description when read in connection with the accompanying drawings .
Brief Description of the Drawings Fig. 1 is a diagram of a current waveform produced by a electrotherapy circuit according to the invention. Fig. 2 is a diagram of the key elements of electrotherapy circuit according to the invention.
Fig. 3 is a schematic diagram of the series- connected resistor circuit shown in the electrotherapy circuit of Fig. 2. Fig. 4 is a schematic diagram of the H-bridge circuit shown in the electrotherapy circuit of Fig. 2.
Fig. 5 is a schematic diagram of the variable resistor shown in the electrotherapy circuit of Fig. 2. Figs. 6-9 are diagrams of current waveforms produced by an electrotherapy circuit according to the invention based on different measured patient impedances.
Figs. 10A and 10B is a set of schedules of the resistance values used for generating the waveforms shown in Figs. 6-10B. Fig. 11 is a table of waveform parameters for various patient impedances in a "normal" mode of operation and a "high-energy" mode of operation of an electrotherapy circuit according to the invention.
Detailed Description With reference to Fig. 1, in operation of an external defibrillator according to the invention, the biphasic current waveform begins with an initial "sensing pulse" 10, which has insufficient energy for performing therapy. The sensing pulse is integral with, i.e., immediately followed by, a biphasic defibrillation waveform having sufficient energy for defibrillating the patient's heart. The biphasic defibrillation waveform includes a six-millisecond, generally rectilinear positive phase 12 having a sawtooth ripple 14, which is in turn followed by a four millisecond negative phase 16 that decays exponentially until the waveform is truncated. As used herein, the term "rectilinear" means having a straight line, regardless of whether the straight line is flat or slightly tilted. The current waveform decreases through a series of steps 18 from the end of the positive phase to the beginning of negative phase, one of the steps being at the zero crossing. Note that for purposes of clarity this 0.1-millisecond transition is not drawn to scale in Fig. 1; if drawn to scale the duration of this transition would be much shorter than shown in Fig. 1.
We believe that a biphasic defibrillation waveform having a positive rectilinear pulse of 6 milliseconds duration followed by 0.1-millisecond transition and a 4 millisecond negative pulse having an initial amplitude equal to the final amplitude of the positive pulse is an especially effective waveform for defibrillation. The negative pulse does not need to be rectilinear.
The basic circuitry for producing the biphasic waveform is shown in Fig. 2. A storage capacitor 20 (115 μF) is charged to a maximum of 2200 volts by a charging circuit 22 while relays 26 and 28 and the H-bridge are open, and then the electric charge stored in storage capacitor 20 is allowed to pass through electrodes 21 and 23 and the body of a patient 24. In particular, relay switches 17 and 19 are opened, and then relay switches 26 and 28 are closed. Then, electronic switches 30, 32, 34, and 36 of H-bridge 48 are closed to allow the electric current to pass through the patient's body in one direction, after which electronic H-bridge switches 30, 32, 34, and 36 are opened and H-bridge switches 38, 40, 42, and 44 are closed to allow the electric current to pass through the patient's body in the opposite direction. Electronic switches 30-44 are controlled by signals from respective opto-isolators, which are in turn controlled by signals from a microprocessor 46, or alternatively a hard-wired processor circuit. Relay switches 26, and 28, which are also controlled by microprocessor 46, isolate patient 24 from leakage currents of bridge switches 30-44, which may be about 500 micro-amps. Relay switches 26 and 28 may be relatively inexpensive because they do not have to "hot switch" the current pulse. They close a few milliseconds before H- bridge 48 is "fired" by closure of some of the H-bridge switches.
Electrodes 21 and 23 may be standard defibrillation electrodes having flat surfaces that adhere to the chest of the patient, but they may alternatively be hand-held paddles that are applied to the chest of the patient or hand-held spoons that are applied directly to the patient's heart during open heart surgery. Storage capacitor 20 may be a single capacitor or a set of series-connected or parallel -connected capacitors . A resistive circuit 50 that includes series- connected resistors 52, 54, and 56 is provided in the current path, each of the resistors being connected in parallel with a shorting switch 58, 60, and 62 controlled by microprocessor 46. The resistors are of unequal value, stepped in a binary sequence to yield 2n possible resistances where n is the number of resistors. During the initial "sensing pulse," when H-bridge switches 30, 32, 34, and 36 are closed, all of the resistor-shorting switches 58, 60, and 62 are in an open state so that the current passes through all of the resistors in series. Current -sensing transformer 64 senses the current passing through the patient 24, from which microprocessor 46 determines the resistance of the patient 24.
The initial sensing pulse is integral with, i.e., immediately followed by, a biphasic defibrillation waveform, and no re-charging of storage capacitor 20 occurs between the initial sensing pulse and the biphasic defibrillation waveform.
If the patient resistance sensed during the initial sensing pulse is low, all of the resistor- shorting switches 58, 60, and 62 are left open at the end of the sensing pulse so that all of the resistors 52, 54, and 56 remain in the current path (the resistors are then successively shorted out during the positive phase of the biphasic defibrillation waveform in the manner described below in order to approximate a rectilinear positive phase) . Thus, the current at the beginning of the positive first phase 12 of the biphasic defibrillation waveform is the same as the current during sensing pulse 10. If the patient resistance sensed during the sensing pulse is high, some or all of the resistor-shorting switches 58, 60, and 62 are closed at the end of the sensing pulse, thereby shorting out some or all of the resistors. This causes an upward jump in current at the end of the sensing pulse as shown in the waveform in Fig. 1.
Thus, immediately after the sensing pulse, the biphasic defibrillation waveform has an initial discharge current that is controlled by microprocessor 46 based on the patient impedance sensed by current -sensing transformer 64.
The current level of the sensing pulse is always at least 50 percent of the current level at the beginning of positive first phase 12, and the sensing pulse, like the defibrillation pulse, is of course a direct-current pulse .
By appropriately selecting the number of resistors that remain in the current path, microprocessor 46 reduces (but does not eliminate) the dependence of peak discharge current on patient impedance, for a given amount of charge stored by the charge storage device. For a patient resistance of 15 ohms the peak current is about 25 amps, whereas for a patient resistance of 125 ohms the peak current is about 12.5 amps (a typical patient impedance is about 75 ohms) .
During the positive phase of the biphasic waveform some or all of the resistors 52, 54, and 56 that remain in series with the patient 24 are successively shorted out. Every time one of the resistors is shorted out, an upward jump in current occurs in the waveform, thereby resulting in the sawtooth ripple shown in the waveform of Fig. 1. The ripple tends to be greatest at the end of the rectilinear phase because the time constant of decay (RC) is shorter at the end of the phase than at the beginning of the phase. Of course, if all of the resistors have already been shorted out immediately after the end of the sensing pulse, the positive phase of the biphasic waveform simply decays exponentially until the waveform switches to the negative phase.
As is shown in Fig. 1, at the end of the positive phase, the current waveform decreases through a series of rapid steps from the end of the positive phase to the beginning of negative phase, one of the steps being at the zero crossing. Microprocessor 46 accomplishes this by 1) successively increasing the resistance of resistive circuit 50 in fixed increments through manipulation of resistor-shorting switches 58, 60, and 62, then 2) opening all of the switches in H-bridge 48 to bring the current waveform down to the zero crossing, then 3) reversing the polarity of the current waveform by closing the H-bridge switches that had previously been open in the positive phase of the current waveform, and then 4) successively decreasing the resistance of resistance circuit 50 in fixed increments through manipulation of resistor-shorting switches 58, 60, and 62 until the resistance of resistance circuit 50 is the same as it was at the end of the positive phase.
In one embodiment a variable resistor 66 is provided in series with the other resistors 52, 54, and 56 to reduce the sawtooth ripple. Every time one of the fixed-value resistors 52, 54, or 56 is shorted out, the resistance of variable resistor 66 automatically jumps to a high value and then decreases until the next fixed- value resistor is shorted out. This tends, to some extent, to smooth out the height of the sawtooth ripple from about 3 amps to about 0.1 to 0.2 amps, and reduces the need for smaller increments of the fixed-value resistors (i.e., it reduces the need for additional fixed-value resistor stages) .
The rectilinear phase may exhibit a degree of tilt, either slightly up, or slightly down. This occurs because of the "graininess" of the steps, because patient impedance may change during the waveform, and because of inherent inaccuracies of circuit elements. For example, with respect to graininess of the steps, calculations might show that, for a 50-ohm patient, the optimal resistance required at the end of the rectilinear phase is 14 ohms, in which case we must choose between 10 or 20 ohms based on the available fixed-value resistors. If we choose 10 ohms, an "error" of 4 ohms would result at the end of the rectilinear phase, and the current would rise by about 6 or 7 percent [ (14-10) / (50+14) ] by the end of the phase. Thus, a 15 amp rectilinear pulse would rise from 15 amps to 16 amps over the rectilinear phase. If it were considered desirable to change this rise to a droop, the microprocessor could easily accommodate such a change. In general, we believe it is desirable to avoid tilt greater than about 20 percent in order to avoid passage of excessive current through the patient's body at the high end of the tilt.
The choices of capacitor (115 μF) and voltage (2200 volts) are based on the desired current requirements and allowable droop during the negative phase. The capacitor stores the minimum energy required to meet the delivered charge requirements (i.e., the charge required to produce the desired current waveform having the desired duration) .
The switches in the left-hand side of H-bridge 48 can be tested by closing switches 17 and 19, opening switches 26 and 28, closing switches 30 and 32, then after a short time closing switches 42 and 44, then after a short time opening switches 30 and 32, and then after a short time opening switches 42 and 44. If the switches are working properly, current-sensing transformer 64 will sense the passage of current when all four switches are closed, and will sense no current when switches 30 and 32 or switches 42 and 44 are open. Otherwise, current- sensing transformer 64 will detect the possible presence of a short circuit or an open circuit . Similarly, the switches in the right-hand side of H-bridge 48 can be tested by closing switches 38 and 40, then after a short time closing switches 34 and 36, then after a short time opening switches 38 and 40, and then after a short time opening switches 34 and 36. This valuable safety test does not require current to pass through the patient, due to the placement of current-sensing transformer 64 outside the legs of H-bridge 48.
Microprocessor 46 easily accommodates a complex environment and functions in harmony with various controls, interlocks, and safety features of the electrotherapy system. In addition to performing the functions described herein, the microprocessor may operate a strip chart, a pacer, an ecg monitor, etc. In the event that additional research should show that the characteristics of current pulses should be different from those described herein, the microprocessor can be re-programmed to alter the current waveforms applied to the patient. For example, the microprocessor could accommodate a waveform change to produce a rising or falling rectilinear ramp voltage with time, or a waveform having a negative phase amplitude less than (or greater than) the positive phase amplitude. Of course, the storage capacitor must have enough stored charge to support the required output .
In an alternative embodiment the negative phase of the current waveform is substantially rectilinear, rather than exponentially decaying, and the techniques described above for providing a substantially rectilinear positive phase would be extended to produce the substantially rectilinear negative phase. Such a substantially rectilinear negative phase would require the use of a higher capacitance and voltage and higher-rated switching devices than those employed in the circuit of Fig. 2 (for a given initial current value of the negative phase) .
Referring to Fig. 3, the resistive circuit 50 of Fig. 2 includes resistors 52 (10 ohms) , 54 (two 10-ohm resistors) , and 56 (four 10-ohm resistors) and IGBT shorting switches 58, 60, and 62. Alternatively, other semiconductor switching devices may be used. The resistor string is designed to switch in 10-ohm steps. This allows for a maximum resistance of 80-ohms (including the 10-ohm variable resistor) , which makes it possible to limit patient current to 21.5 amps for a 15- ohm patient resistance (the current pulse would be 25.6 amps in the event of a short circuit between the electrodes) .
The values of the resistors, as well as the 115 μF value of the storage capacitor and the capacitor voltage of 2200 volts, are determined by the current required to be delivered into the patient load (about 12.5 - 25 amps) and the range of the patient load (e.g., 125 ohms - 15 ohms) . The IGBT shorting switches are switched on and off by means of opto-isolator circuits 68, 70, and 72 controlled by the microprocessor. Referring to Fig. 4, H-bridge 48 of Fig. 2 includes IGBT switches 30-44 similarly switched on and off by means of opto-isolator circuits 74, 76, 78, and 80 controlled by the microprocessor. Alternatively, switches 30-44 may be other types of semiconductor switching devices . Only one opto-isolator is provided to control each pair of switches in each arm of the H-bridge.
Referring to Fig. 5, variable resistor 66 of Fig. 2 includes resistor 82 connected between resistive circuit 50 and storage capacitor 20. The effective resistance of variable resistor 66 is controlled by the circuitry connected in parallel with resistor 82, through which some of the current from storage capacitor 20 to resistive circuit 50 can pass. In particular, whenever the microprocessor shorts out one of the fixed-value resistors in resistive circuit 50, it also shorts capacitor 84. This causes transistor 86 to turn on, which pulls the gate of FET or IGBT transistor 88 to ground, thereby turning transistor 88 off. Because transistor 88 is turned off, all of the current from storage capacitor 20 to resistive circuit 50 passes through resistor 82.
Capacitor 84 then begins to charge linearly because of the current source in the collector of transistor 86. This causes the voltage at the drain/collector of transistor 88 to increase linearly, which causes the current in transistor 88 to increase linearly. When the current in transistor 88 increases, the current passing through resistor 82 decreases, thereby reducing the voltage across resistor 82 and therefore reducing the effective resistance of variable resistor 66.
The electrotherapy circuit can be operated in either a "normal" mode of operation or a "high-energy" mode of operation. These two modes of operation are identical when the sensed patient impedance is below 40 ohms. If the sensed patient impedance is above 40 ohms, however, the microprocessor selects an initial resistance value of the series-connected resistors (after the sensing pulse) that depends on the mode of operation. In particular, in the "high-energy" mode of operation the microprocessor selects a lower initial resistance than in the "normal" mode of operation. Thus, more energy will be delivered to the patient in the "high-energy" mode of operation than in the "normal" mode of operation. A practitioner may try to defibrillate in the "normal" mode, then switch to the "high-energy" mode if unsuccessful .
In the "high-energy" mode of operation of the circuit, if the sensed patient impedance is sufficiently high (above 85 ohms) all of the resistor-shorting switches are closed after the initial "sensing pulse," thereby shorting out all of the series-connected resistors. This causes an upward jump at the end of the "sensing pulse," after which the positive and negative phases of the biphasic waveform both decay exponentially.
Referring to the table of Figs. 10A and 10B and the waveforms of Figs. 6-9, which correspond to certain schedules in the table of Figs. 10A and 10B, the microprocessor schedules the resistance values of the series-connected resistors based on the measured patient impedance, in a manner such that the stepwise resistance decrease of the series-connected resistors over the course of the rectilinear phase matches the decrease in voltage of the storage capacitor. For the sake of simplicity, the initial sensing pulse and the series of steps between the end of the positive phase and the beginning of negative phase have been omitted from Figs. 6-9, and it is assumed the variable resistor discussed above is not used. Figs. 6-9 are all examples of the "high-energy" mode. Fig. 6, which corresponds to Schedule 3A in Fig. 10A, is based on a patient impedance of 50 ohms, in which case the microprocessor selects an initial series-connected resistance of 30 ohms and a residual series-connected resistance of 0 ohms at the end of the positive phase. The total energy delivered to the patient is about 182 joules. Fig. 7, corresponding to Schedule 4A, is based on a patient impedance of 75 ohms, an initial resistance of 10 ohms, a residual resistance of 0 ohms, and an energy of 222 joules. Fig. 8, corresponding to Schedule 5A, is based on a patient impedance of 100 ohms, an initial resistance of 0 ohms, and a residual resistance of 0 ohms, and an energy of 217 joules. Fig. 9, corresponding to Schedule 5A, is based on a patient impedance of 125 ohms, an initial resistance of 40 ohms, a residual resistance of 0 ohms, and an energy of 199 joules.
Fig. 11 includes a table, corresponding to the "normal" mode of operation, that identifies, as a function of the patient impedance, the positive-phase current (in amps), ripple (in amps, assuming the variable resistor is not used) , tilt of the negative phase (expressed as a percentage of the initial current value of the negative phase) , total delivered energy (in joules) , and the deviation of the total delivered energy from the normal mode's "rating" of 150 joules. Fig. 11 also includes a similar table for the "high-energy" mode of operation, identifying positive-phase current, tilt of the positive phase (based on a straight-line average through the ripples) , ripple, tilt of the negative phase, total delivered energy, and the deviation of the total delivered energy from the "rating" of 170 joules.
In both the high-energy and normal modes described above, the storage capacitor is charged to its maximum voltage of 2200 volts. Other modes of operation can be developed in which the storage capacitor is charged to a lesser voltage, or in which different resistance schedules are used.
There have been described novel and improved electrotherapy circuits and techniques for using them. It is evident that those skilled in the art may now make numerous uses and modifications of and departures from the specific embodiment described herein without departing from the inventive concept. For example, the techniques described herein can be used in connection with implantable defibrillators rather than external defibrillators or in connection with electrotherapy circuits other than defibrillator circuits or even circuits that perform functions other than electrotherapy.
What is claimed is:

Claims

1. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device located externally of a patient's body; discharging the charge storage device through the patient's body through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple.
2. The method of claim 1 wherein the step of discharging the charge storage device comprises applying the current waveform as a defibrillation pulse to a patient.
3. The method of claim 1 wherein the step of discharging the charge storage device comprises applying the current waveform transthoracically to a patient.
4. The method of claim 1 wherein the ripple has a height less than one third the height of the peak current of the phase having the ripple.
5. The method of claim 4 wherein the ripple has a height less than one fourth the height of the peak current of the phase having the ripple .
6. The method of claim 5 wherein the ripple has a height less than one fifth the height of the peak current of the phase having the ripple.
7. The method of claim 1 wherein the phase that includes the ripple is followed by another phase of the current waveform having a polarity opposite that of the phase that includes the ripple.
8. The method of claim 1 wherein the ripple has more than two teeth.
9. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two non- implanted discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a control circuit connected to the charge storage device, that controls a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple.
10. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple with a height less than one-third the height of the peak current of the phase.
11. The method of claim 10 wherein the ripple has a height less than one-fourth the height of the peak current of the phase .
12. The method of claim 11 wherein the ripple has a height less than one- fifth the height of the peak current of the phase .
13. The method of claim 10 wherein the charge storage device is located externally of a patient's body through which the charge storage device is discharged during the discharging step.
14. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a control circuit connected to the charge storage device, that controls a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple with a height less than one-third the height of the peak current of the phase.
15. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase.
16. The method of claim 15 wherein the difference between the peak current of the phase and the lowest current of the phase is less than one- fourth of the peak current of the phase .
17. The method of claim 16 wherein the difference between the peak current of the phase and the lowest current of the phase is less than one-fifth of the peak current of the phase.
18. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a control circuit connected to the charge storage device, that controls a continuous discharge of the charge storage device through the electrodes so as to produce at least one phase of a current waveform that includes a ripple wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase.
19. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling a continuous discharge of the charge storage device through the electrodes so as to produce one phase of a current waveform wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, followed by another phase of the current waveform having a polarity opposite to that of the one phase and a duration less than that of the one phase.
20. The method of claim 19 wherein the duration of the one phase is between fifty and seventy percent of the combined duration of the one phase and the other phase.
21. The method of claim 20 wherein the duration of the one phase is about three-fifths of the combined duration of the one phase and the other phase.
22. The method of claim 20 wherein duration of the one phase is about five-eighths of the combined duration of the one phase and the other phase.
23. The method of claim 19 wherein the difference between the peak current of the phase and the lowest current of the phase is less than one fourth of the peak current of the phase.
24. The method of claim 19 wherein the phase in which the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase comprises a ripple.
25. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a control circuit connected to the charge storage device, that controls a continuous discharge of the charge storage device through the electrodes so as to produce one phase of a current waveform wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, followed by another phase of the current waveform having a polarity opposite to that of the one phase and a duration less than that of the one phase.
26. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling a continuous discharge of the charge storage device through the electrodes so as to produce one phase of a current waveform wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, followed by another phase of the current waveform in the form of a truncated exponential and having a polarity opposite to that of the one phase.
27. The method of claim 26 wherein the difference between the peak current of the phase and the lowest current of the phase is less than one- fourth of the peak current of the phase .
28. The method of claim 27 wherein the difference between the peak current of the phase and the lowest current of the phase is less than one-fifth of the peak current of the phase .
29. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a control circuit connected to the charge storage device, that controls a continuous discharge of the charge storage device through the electrodes so as to produce one phase of a current waveform wherein the difference between the peak current of the phase and the lowest current of the phase is less than one third of the peak current of the phase, followed by another phase of the current waveform in the form of a truncated exponential and having a polarity opposite to that of the one phase.
30. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a resistive circuit connected between the charge storage device and one of the electrodes; and a control circuit, connected to the resistive circuit, that controls the resistance of the resistive circuit during discharge of the charge storage device so as to shape a current waveform produced between the discharge electrodes.
31. The electrotherapy circuit of claim 30 wherein the control circuit controls the resistance of the resistive circuit during discharge of the charge storage device so as to produce a current waveform having at least one rectilinear phase.
32. The electrotherapy circuit of claim 31 wherein the rectilinear phase comprises a ripple.
33. The electrotherapy circuit of claim 31 wherein the rectilinear phase comprises a tilt.
34. The electrotherapy circuit of claim 33 wherein the tilt is no more than about twenty percent.
35. The electrotherapy circuit of claim 30 wherein the resistive circuit comprises a plurality of discrete resistors.
36. The electrotherapy circuit of claim 35 further comprising a switching circuit connected to the plurality of resistors that selectively provides at least one path for flow of electric current from the charge storage device through a subset of the plurality of resistors to one of the discharge electrodes.
37. The electrotherapy circuit of claim 36 wherein the control circuit controls the switching circuit to select the subset of the resistors through which the electric current flows, the control circuit selecting different subsets of the resistors during different portions of discharge of the charge storage device so as to produce a rectilinear current waveform.
38. The electrotherapy circuit of claim 36 wherein the resistors are connected together in series.
39. The electrotherapy circuit of claim 38 wherein the switching circuit selectively provides the path for flow of electric current by shorting out resistors not in the subset through which the path extends .
40. The electrotherapy circuit of claim 39 wherein the resistive circuit further comprises a variable resistor, and the control circuit resets the variable resistor to a high resistance value every time one of the discrete resistors is shorted out and then allows the variable resistor to decrease to a low resistance value.
41. The electrotherapy circuit of claim 39 wherein, at the end of a first phase of the waveform, the switching circuit rapidly and successively adds resistors to the subset through which the path extends to cause the waveform to the step down to a value of zero.
42. The electrotherapy circuit of claim 41 wherein, at the beginning of the second phase of the waveform, the switching circuit rapidly and successively shorts out resistors in the subset through which the path extends to cause the waveform to step down from the value of zero to a negative value.
43. The electrotherapy circuit of claim 35 wherein the resistors are stepped in a binary sequence.
44. The electrotherapy circuit of claim 30 further comprising at least one switch connected between the charge storage device and one of the electrodes that, when closed, creates a closed circuit for flow of current from the charge storage device to the electrodes .
45. The electrotherapy circuit of claim 44 wherein the at least one switch comprises a plurality of switches arranged as an H-bridge.
46. The electrotherapy circuit of claim 30 wherein the current waveform comprises a first phase and a second phase having a polarity opposite to the first phase.
47. The electrotherapy circuit of claim 30 wherein the control circuit comprises a microprocessor.
48. The electrotherapy circuit of claim 30 wherein the control circuit is hard-wired.
49. The electrotherapy circuit of claim 30 wherein the current waveform comprises a defibrillation pulse.
50. The electrotherapy circuit of claim 30 wherein the electrodes are non-implanted.
51. The electrotherapy circuit of claim 30 wherein the charge storage device comprises at least one capacitor.
52. The electrotherapy circuit of claim 30 wherein the charge storage device is a single capacitor.
53. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device, and through a resistive circuit connected between the charge storage device and one of the electrodes; and controlling the resistance of the resistive circuit during discharge of the charge storage device so as to shape a current waveform produced between the discharge electrodes.
54. The method of claim 53 wherein the resistive circuit comprises a plurality of discrete resistors and the step of controlling the resistance of the resistive circuit comprises selectively providing at least one path for flow of electric current from the charge storage device through a subset of the plurality of resistors to one of the discharge electrodes .
55. The method of claim 54 wherein the step of providing the path for flow of electric current comprises selecting different subsets of the resistors during different portions of discharge of the charge storage device so as to produce a rectilinear current waveform.
56. The method of claim 54 wherein the resistors are connected together in series and the step of providing the path for flow of electric current comprises shorting out resistors not in the subset through which the path extends .
57. The method of claim 53 further comprising the step of applying the electrodes externally to the patient prior to discharging the charge storage device.
58. The method of claim 57 wherein the electrodes are externally applied directly to the patient's heart during surgery.
59. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a variable impedance connected between the charge storage device and one of the electrodes; a sensor that senses a patient -dependent electrical parameter; and a control circuit, connected to the sensor and the variable impedance, that controls the impedance of the variable impedance during discharge of the charge storage device based on the patient-dependent electrical parameter sensed by the sensor.
60. The electrotherapy circuit of claim 59 wherein the patient -dependent electrical parameter comprises impedance of the patient .
61. The electrotherapy circuit of claim 59 wherein the control circuit controls the variable impedance in a manner so as to reduce dependence of peak discharge current on the patient-dependent electrical parameter.
62. The electrotherapy circuit of claim 61 wherein the control circuit selects the impedance of the variable impedance inversely with respect to the impedance of the patient as sensed by the sensor.
63. The electrotherapy circuit of claim 62 wherein the peak discharge current if the impedance of the patient is 15 ohms is no more than about twice the peak discharge current if the impedance of the patient is 125 ohms.
64. The electrotherapy circuit of claim 61 wherein the discharge of the charge storage device comprises a current waveform having a sensing pulse portion during which the sensor senses the impedance of the patient between the electrodes, and a therapeutic discharge portion during which the control circuit selects the impedance of the variable impedance inversely with respect to the impedance of the patient as sensed by the sensor.
65. The electrotherapy circuit of claim 59 wherein the sensor is a current sensor.
66. The electrotherapy circuit of claim 65 wherein the sensor is a current sense transformer.
67. The electrotherapy circuit of claim 59 wherein the variable impedance comprises a variable resistive circuit.
68. The electrotherapy circuit of claim 64 wherein the therapeutic discharge portion of the current waveform is rectilinear.
69. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; sensing a patient -dependent electrical parameter; and discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device, and through a variable impedance connected between the charge storage device and one of the electrodes; and controlling the impedance of the variable impedance during discharge of the charge storage device based on the sensed patient-dependent electrical parameter.
70. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a sensor that senses a patient-dependent electrical parameter; and a control circuit, connected to the sensor and the charge storage device, that controls discharge of the charge storage device through the electrodes, based on the patient-dependent electrical parameter as sensed by the sensor, in a manner so as to reduce the dependence of peak discharge current on the electrical parameter for a given amount of charge stored by the charge storage device.
71. The electrotherapy circuit of claim 70 further comprising a variable impedance connected between the charge storage device and one of the electrodes, the control circuit being connected to the variable impedance and controlling discharge of the charge storage device by controlling the variable impedance during discharge of the charge storage device.
72. A method of forming an electrotherapy current waveform, comprising the steps of : charging a charge storage device; sensing a patient-dependent electrical parameter; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; and controlling discharge of the charge storage device through the electrodes, based on the patient-dependent electrical parameter, in a manner so as to reduce dependence of peak discharge current on electrical parameter for a given amount of charge stored by the charge storage device.
73. The method of claim 72 wherein: the storage device is discharged through a variable impedance connected between the charge storage device and one of the electrodes; and the step of controlling discharge of the charge storage device comprises controlling the variable impedance during discharge of the charge storage device based on the patient-dependent electrical parameter.
74. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a sensor that senses a patient-dependent electrical parameter; and a control circuit, connected to the sensor and the charge storage device, that controls discharge of the charge storage device through the electrodes, the discharge of the charge storage device comprising a current waveform having a sensing pulse portion, with insufficient energy for performing therapy, during which the sensor senses a patient -dependent electrical parameter, and a therapeutic discharge portion, with sufficient energy for performing therapy, having an initial discharge current controlled by the control circuit based on the patient-dependent electrical parameter as sensed by the sensor, the sensing pulse portion having a discharge current that is at least about one-third of the initial discharge current of the therapeutic discharge portion.
75. The electrotherapy circuit of claim 74 wherein the sensing pulse portion has a discharge current that is at least about half the initial discharge current of the therapeutic discharge portion.
76. The electrotherapy circuit of claim 74 wherein the sensing pulse portion has a non-alternating discharge current.
77. The electrotherapy circuit of claim 74 wherein the discharge of the charge storage device occurs without recharging of the charge storage device between the sensing pulse portion and the therapeutic discharge portion of the current waveform.
78. The electrotherapy circuit of claim 74 wherein the control circuit controls discharge of the charge storage device through the electrodes, based on the patient-dependent electrical parameter as sensed by the sensor, in a manner so as to reduce dependence of peak discharge current on the patient-dependent electrical parameter during the therapeutic discharge portion of the current waveform.
79. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; sensing a patient -dependent electrical parameter during a sensing pulse portion of the discharge of the charge storage device, the sensing pulse portion having insufficient energy for performing therapy; and controlling an initial discharge current of a therapeutic discharge portion of the discharge of the charge storage device, the therapeutic discharge portion having sufficient energy for performing therapy, based on the sensed patient-dependent electrical parameter, the sensing pulse portion having a discharge current that is at least about one-third the initial discharge current of the therapeutic discharge portion.
80. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device; at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; a sensor that senses a patient-dependent electrical parameter; and a control circuit, connected to the sensor and the charge storage device, that controls discharge of the charge storage device through the electrodes, the discharge of the charge storage device comprising a current waveform having a sensing pulse portion, with insufficient energy for performing therapy, during which the sensor senses a patient -dependent electrical parameter, and a therapeutic discharge portion, with sufficient energy for performing therapy, having an initial discharge current controlled by the control circuit based on the patient -dependent electrical parameter as sensed by the sensor during the sensing pulse portion, the discharge of the charge storage device occurring without recharging of the charge storage device between the sensing pulse portion and the therapeutic discharge portion of the current waveform.
81. The electrotherapy circuit of claim 80 wherein the sensing pulse portion is integral with the therapeutic discharge portion.
82. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to opposite poles of the charge storage device; sensing a patient-dependent electrical parameter during a sensing pulse portion of the discharge of the charge storage device, the sensing pulse portion having insufficient energy for performing therapy; and controlling an initial discharge current of a therapeutic discharge portion of the discharge of the charge storage device, the therapeutic discharge portion having sufficient energy for performing therapy, based on the sensed patient -dependent electrical parameter, the step of discharging the charge storage device being performed without recharging the charge storage device between the sensing pulse portion and the therapeutic discharge portion of the current waveform.
83. A method of forming an electrotherapy current waveform, comprising the steps of: charging a charge storage device having opposite poles; discharging the charge storage device through at least two discharge electrodes connected by electrical circuitry to the opposite poles of the charge storage device, the discharge of the charge storage device having a sensing pulse portion having insufficient energy for performing therapy and a discharge portion having sufficient energy for performing therapy; sensing a patient -dependent electrical parameter during the sensing pulse portion of the discharge of the charge storage device; and controlling an initial discharge current of the therapeutic discharge portion of the discharge of the charge storage device, based on the sensed patient- dependent electrical parameter; the sensing pulse portion of the current waveform being integral with the therapeutic discharge portion of the current waveform.
84. An electrotherapy circuit for administering to a patient a current waveform, comprising: a charge storage device having opposite poles; at least two discharge electrodes connected by electrical circuitry to the opposite poles of the charge storage device; a sensor that senses a patient-dependent electrical parameter during a sensing pulse portion of a current waveform, the sensing pulse portion having insufficient energy for performing therapy; and a control circuit, connected to the sensor and the charge storage device, for controlling discharge of the charge storage device through the electrodes, the discharge of the charge storage device comprising the current waveform having the sensing pulse portion during which the sensor senses a patient-dependent electrical parameter, the current waveform also having a therapeutic discharge portion, with sufficient energy for performing therapy, having an initial discharge current controlled by the control circuit based on the patient -dependent electrical parameter as sensed by the sensor, the sensing pulse portion of the current waveform being integral with the therapeutic discharge portion of the current waveform.
EP97954585A 1996-12-18 1997-12-16 Electrotherapy current waveform Expired - Lifetime EP0973582B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05075510A EP1535645A1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US08/769,773 US6096063A (en) 1996-12-18 1996-12-18 Electrotherapy circuit having controlled current discharge based on patient-dependent electrical parameter
US08/769,045 US5800462A (en) 1996-12-18 1996-12-18 Electrotherapy circuit for producing therapeutic discharge waveform based on high-current sensing pulse
US769046 1996-12-18
US769773 1996-12-18
US08/769,046 US5797968A (en) 1996-12-18 1996-12-18 Electrotherapy circuit for producing current waveform with sawtooth ripple
US08/769,778 US5769872A (en) 1996-12-18 1996-12-18 Electrotherapy circuit and method for shaping current waveforms
US769045 1996-12-18
US769776 1996-12-18
US08/769,776 US5733310A (en) 1996-12-18 1996-12-18 Electrotherapy circuit and method for producing therapeutic discharge waveform immediately following sensing pulse
US769777 1996-12-18
US769778 1996-12-18
US08/769,777 US5800463A (en) 1996-12-18 1996-12-18 Electrotherapy circuit having controlled peak current
US08/910,757 US5904706A (en) 1996-12-18 1997-08-13 Method and apparatus for producing electrotherapy current waveform with ripple
US910757 1997-08-13
PCT/US1997/023400 WO1998026841A1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05075510A Division EP1535645A1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform

Publications (3)

Publication Number Publication Date
EP0973582A1 true EP0973582A1 (en) 2000-01-26
EP0973582A4 EP0973582A4 (en) 2001-02-07
EP0973582B1 EP0973582B1 (en) 2005-05-11

Family

ID=27569916

Family Applications (2)

Application Number Title Priority Date Filing Date
EP05075510A Withdrawn EP1535645A1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform
EP97954585A Expired - Lifetime EP0973582B1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP05075510A Withdrawn EP1535645A1 (en) 1996-12-18 1997-12-16 Electrotherapy current waveform

Country Status (4)

Country Link
EP (2) EP1535645A1 (en)
JP (1) JP4108758B2 (en)
DE (1) DE69733276T2 (en)
WO (1) WO1998026841A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788699B1 (en) 1999-01-27 2001-05-25 Bruker Medical Sa PULSES OR SERIES OF DEFIBRILLATION PULSES AND DEVICE FOR GENERATING THE SAME
FR2879937B1 (en) * 2004-12-23 2008-01-11 Schiller Medical Sas DEFIBRILLATOR WHERE THE DISCHARGE CIRCUIT IS SECURED AND HAS AN H-BRIDGE
CN101378804B (en) 2006-02-01 2013-09-25 皇家飞利浦电子股份有限公司 Energy efficient defibrillation current limiter
US8116865B2 (en) 2007-12-13 2012-02-14 Cardiac Pacemarkers, Inc. Defibrillation shock output circuit
JP5563652B2 (en) 2009-03-17 2014-07-30 カーディオスライヴ インコーポレイテッド External defibrillator
US8433404B2 (en) 2009-05-19 2013-04-30 Cardiac Pacemakers, Inc. Integrated high voltage output circuit
BRPI1009724A2 (en) 2009-06-19 2016-03-15 Koninkl Philips Electronics Nv "external defibrillator applying biphasic defibrillation pulses"
EP2446927A1 (en) * 2010-10-28 2012-05-02 Schiller Medical S.A.S. Ultra-short high voltage electric defibrillation pulses
US10149973B2 (en) 2013-06-14 2018-12-11 Cardiothrive, Inc. Multipart non-uniform patient contact interface and method of use
US9833630B2 (en) 2013-06-14 2017-12-05 Cardiothrive, Inc. Biphasic or multiphasic pulse waveform and method
US10279189B2 (en) 2013-06-14 2019-05-07 Cardiothrive, Inc. Wearable multiphasic cardioverter defibrillator system and method
US9616243B2 (en) 2013-06-14 2017-04-11 Cardiothrive, Inc. Dynamically adjustable multiphasic defibrillator pulse system and method
ES2828361T3 (en) 2014-02-24 2021-05-26 Element Science Inc External defibrillator
WO2017035502A1 (en) 2015-08-26 2017-03-02 Element Science, Inc. Wearable devices
KR102187629B1 (en) * 2018-01-19 2020-12-07 주식회사 아모센스 Apparatus for controlling output of skin care device
KR102187563B1 (en) * 2018-01-19 2020-12-07 주식회사 아모센스 Apparatus and method for controlling output of skin care device
US20210046308A1 (en) * 2018-01-19 2021-02-18 AMOSENSE Co.,Ltd Apparatus and method for controlling output of skin care device
EP3863511A4 (en) 2018-10-10 2022-04-06 Element Science, Inc. Wearable medical device with disposable and reusable components
EP4157439A1 (en) * 2020-05-26 2023-04-05 Zoll Medical Corporation Electrotherapeutic waveform and pulse generation and delivery system and method
US11638819B2 (en) 2020-09-11 2023-05-02 Galvanize Therapeutics, Inc. Signal generators for use with tissue modification systems

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4823796A (en) * 1987-04-03 1989-04-25 Laerdal Manufacturing Corp. Defibrillator circuit for producing a trapezoidal defibrillation pulse
EP0546666A2 (en) * 1991-11-08 1993-06-16 Physio-Control Corporation Electronic energy transfer circuit
US5350403A (en) * 1992-06-17 1994-09-27 Siemens Aktiengesellschaft Apparatus for charging living tissue with electrical pulses
US5391186A (en) * 1993-12-13 1995-02-21 Angeion Corporation Method and apparatus for utilizing short tau capacitors in an implantable cardioverter defibrillator
US5431687A (en) * 1993-04-09 1995-07-11 Angeion Corporation Impedance timed defibrillation system
US5531764A (en) * 1992-03-24 1996-07-02 Angeion Corporation Implantable defibrillator system and method having successive changeable defibrillation waveforms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3258013A (en) * 1963-07-01 1966-06-28 Zenith Radio Corp Defibrillators
US3886950A (en) * 1973-10-01 1975-06-03 Spacelabs Inc Defibrillator
DE68925218T2 (en) * 1988-01-19 1996-07-25 Telectronics Nv Method and apparatus for the application of asymmetric, two-phase, cut off exponential counter shocks
DE4007211A1 (en) * 1990-03-07 1991-09-12 Mueller Gerhard ELECTRICAL CIRCUIT TO PROVIDE A HIGH VOLTAGE PULSE, IN PARTICULAR FOR A DEFIBRILLATOR
US5199429A (en) 1991-05-23 1993-04-06 Angemed, Inc. Implantable defibrillator system employing capacitor switching networks
US5507781A (en) * 1991-05-23 1996-04-16 Angeion Corporation Implantable defibrillator system with capacitor switching circuitry
US5230336A (en) 1991-08-16 1993-07-27 Ventritex, Inc. Method and apparatus for impedance based automatic pulse duration adjustment for defibrillation shock delivery
EP0553864B1 (en) * 1992-01-30 1999-10-27 Cardiac Pacemakers, Inc. Defibrillator waveform generator for generating waveform of long duration
US5306291A (en) * 1992-02-26 1994-04-26 Angeion Corporation Optimal energy steering for an implantable defibrillator
DE59209886D1 (en) * 1992-05-12 2001-02-15 Pacesetter Ab Jaerfaella Implantable defibrillation system
US5607454A (en) 1993-08-06 1997-03-04 Heartstream, Inc. Electrotherapy method and apparatus
US5908442A (en) * 1996-04-12 1999-06-01 Survivalink Corporation Stepped truncated damped sinusoidal defibrillation waveform

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4823796A (en) * 1987-04-03 1989-04-25 Laerdal Manufacturing Corp. Defibrillator circuit for producing a trapezoidal defibrillation pulse
EP0546666A2 (en) * 1991-11-08 1993-06-16 Physio-Control Corporation Electronic energy transfer circuit
US5531764A (en) * 1992-03-24 1996-07-02 Angeion Corporation Implantable defibrillator system and method having successive changeable defibrillation waveforms
US5350403A (en) * 1992-06-17 1994-09-27 Siemens Aktiengesellschaft Apparatus for charging living tissue with electrical pulses
US5431687A (en) * 1993-04-09 1995-07-11 Angeion Corporation Impedance timed defibrillation system
US5391186A (en) * 1993-12-13 1995-02-21 Angeion Corporation Method and apparatus for utilizing short tau capacitors in an implantable cardioverter defibrillator

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9826841A1 *

Also Published As

Publication number Publication date
JP4108758B2 (en) 2008-06-25
DE69733276T2 (en) 2006-05-04
EP0973582A4 (en) 2001-02-07
EP0973582B1 (en) 2005-05-11
DE69733276D1 (en) 2005-06-16
JP2001506157A (en) 2001-05-15
WO1998026841A1 (en) 1998-06-25
EP1535645A1 (en) 2005-06-01

Similar Documents

Publication Publication Date Title
US5733310A (en) Electrotherapy circuit and method for producing therapeutic discharge waveform immediately following sensing pulse
US6096063A (en) Electrotherapy circuit having controlled current discharge based on patient-dependent electrical parameter
US5769872A (en) Electrotherapy circuit and method for shaping current waveforms
EP0973582B1 (en) Electrotherapy current waveform
US5735879A (en) Electrotherapy method for external defibrillators
US5749904A (en) Electrotherapy method utilizing patient dependent electrical parameters
US6241751B1 (en) Defibrillator with impedance-compensated energy delivery
EP0808639B1 (en) Patient-worn energy delivery apparatus
EP1118353B1 (en) Charge-based defibrillation apparatus
US7079894B2 (en) Damped biphasic energy delivery circuit for a defibrillator
US5797968A (en) Electrotherapy circuit for producing current waveform with sawtooth ripple
EP1866029A1 (en) Defibrillator with impedance-compensated energy delivery
US5904706A (en) Method and apparatus for producing electrotherapy current waveform with ripple
US5800462A (en) Electrotherapy circuit for producing therapeutic discharge waveform based on high-current sensing pulse
US5800463A (en) Electrotherapy circuit having controlled peak current
EP0956095B1 (en) Hochenergiedefibrillator mit stromkontrollschaltung
EP1981591B1 (en) Energy efficient defibrillation current limiter
EP1458445B1 (en) Apparatus for delivering defibrillation and pacing energy from a single power source
EP0888149B1 (en) Electrotherapy apparatus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB

A4 Supplementary search report drawn up and despatched

Effective date: 20001222

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB

PUAF Information related to the publication of a search report (a3 document) modified or deleted

Free format text: ORIGINAL CODE: 0009199SEPU

D17D Deferred search report published (deleted)
DA4 Supplementary search report drawn up and despatched (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20010703

17Q First examination report despatched

Effective date: 20031001

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69733276

Country of ref document: DE

Date of ref document: 20050616

Kind code of ref document: P

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

ET Fr: translation filed
26N No opposition filed

Effective date: 20060214

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20151229

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20151217

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20151229

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69733276

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20161216

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20170831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161216

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170701